The Chinese of Hong Kong | Hong Kong

Author Profile

EARLY ACADEMIC PURSUITS

Dr. Jingying Zhou commenced her academic journey by earning a Ph.D. in Microbiology from The University of Hong Kong (HKU) in 2013. Prior to her doctoral studies, she obtained an M.Phil. in Virology and Microbiology from Wuhan University in 2008, following a Bachelor of Science degree in Biology from the same university in 2005.

PROFESSIONAL ENDEAVORS

After completing her Ph.D., Dr. Zhou embarked on a productive period as a Postdoctoral Fellow at the School of Biomedical Sciences (SBS), CUHK, spanning from September 2013 to September 2018. Demonstrating her commitment to academic research, she then assumed the role of Research Assistant Professor at SBS, CUHK, where she continued to contribute significantly to the field until February 2022.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC VARIATION AND ITS IMPACT ON DISEASE

During her tenure as a Postdoctoral Fellow and Research Assistant Professor, Dr. Zhou delved into T cell-based immunotherapies in cancers. Her research explored the intricate dynamics of the liver microenvironment in the context of cancer metastasis and immunotherapy resistance. These efforts significantly contributed to the understanding of novel treatment modalities in cancer research.

IMPACT AND INFLUENCE

Dr. Zhou's work has had a noteworthy impact on the field, shaping the discourse on T cell-based immunotherapies and providing insights into the complexities of the liver microenvironment. Her research has garnered attention for its potential implications in addressing challenges related to cancer metastasis and immunotherapy resistance.

ACADEMIC CITATIONS

Dr. Zhou's work has likely served as a reference point for fellow researchers and clinicians working in the domain of cancer immunotherapy and microenvironment studies.

LEGACY AND FUTURE CONTRIBUTIONS

As of February 2022, Dr. Jingying Zhou holds the position of Assistant Professor at SBS, CUHK, marking the continuation of her academic journey. Her appointment to this role underscores her dedication to advancing knowledge in the field. Given her track record, it is anticipated that Dr. Zhou will leave a lasting legacy through her ongoing and future contributions to microbiology and cancer research.

Notable Publications

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma 2023(11)

Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients 2023(5)

Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma 2023(9)

Ahmad Ismaili | Plant Disease | Best Researcher Award

Posted on 19/01/202416/02/2024 by PencisLeave a Comment

Prof Ahmad Ismaili | Plant Disease | Best Researcher Award

Lorestan University | Iran

Author Profile

Scopus

EARLY ACADEMIC PURSUITS:

Ahmad Ismaili embarked on his academic journey with a Bachelor's degree in Agronomy and Plant Breeding from Shahid Chamran (Jondi Shapour) University in Ahvaz, Iran, in 1999. This foundational education laid the groundwork for his future pursuits in the field of plant science and biotechnology.

PROFESSIONAL ENDEAVORS:

Continuing his academic pursuits, Ismaili earned a Master's degree in Plant Breeding from Tarbiat Modarres University in Tehran, Iran, in 2002. This advanced degree marked a significant step forward in his academic and professional development. Undeterred, he pursued a Ph.D. in Plant Breeding with a focus on Genetic Engineering and Molecular Genetics, completing his doctorate in 2006 at Tarbiat Modarres University.

CONTRIBUTIONS AND RESEARCH FOCUS ON PLANT DISEASE:

As an Academic and Scientific Member of Lorestan University, Iran, Ahmad Ismaili has made substantial contributions to the field of plant biotechnology, particularly in Molecular Genetic and Genetic Engineering. His research has likely encompassed a diverse range of topics within these fields, demonstrating a commitment to advancing scientific knowledge and technological applications in agriculture.

IMPACT AND INFLUENCE:

Ismaili's impact extends beyond his individual research, as evidenced by his role in supervising 19 Ph.D. students and 60 M.Sc. students. His mentorship has likely played a crucial role in shaping the next generation of researchers and professionals in the field of plant science and biotechnology.

ACADEMIC CITES:

The impact of Ismaili's work is further underscored by his membership in prominent scientific societies, such as the Iranian Genetic Society (Branch of Plant) and the Iranian Biotechnology Society. These affiliations indicate his active engagement with the broader scientific community and his commitment to staying abreast of developments in the rapidly evolving field of biotechnology.

LEGACY AND FUTURE CONTRIBUTIONS:

As an established Professor in Plant Biotechnology, Ismaili has likely left a lasting legacy at Lorestan University. His dedication to education, research, and mentorship has undoubtedly contributed to the academic growth of the institution. Looking ahead, his future contributions may involve further research breakthroughs, continued mentorship, and a sustained commitment to advancing knowledge in plant biotechnology.

Notable Publications:

A Comparative Proteomic Analysis of Responses to High Temperature Stress in Hypocotyl of Canola (Brassica napus L.) 2015(22)

Laura Warmke | Pathology | Best Researcher Award

Posted on 11/01/202417/02/2024 by PencisLeave a Comment

Dr. Laura Warmke | Pathology | Best Researcher Award

University of Indiana School of Medicine | United States

Author Profile

Orcid ID

EARLY ACADEMIC PURSUITS:

During my undergraduate years from 2005 to 2009 at the University of Virginia, I pursued a Bachelor of Science in Chemistry with Distinction, accompanied by a Minor in Studio Art. This foundational period laid the groundwork for my multifaceted approach to learning, blending the analytical rigor of the sciences with the creative elements of studio art.

PROFESSIONAL ENDEAVORS:

In 2010, I embarked on the journey towards a Doctor of Medicine (M.D.) degree at the Virginia Commonwealth University School of Medicine in Richmond, VA. This phase of my education marked the transition from theoretical knowledge to the practical application of medical expertise, fostering my commitment to the field of pathology.

CONTRIBUTIONS AND RESEARCH FOCUS ON PATHOLOGY:

Throughout my residency at Virginia Commonwealth University Health System (2014-2017), I actively engaged in the field of Anatomic Pathology/Clinical Pathology (AP/CP), developing a keen interest in bone and soft tissue pathology. This interest led me to pursue specialized training, culminating in my Selective Bone & Soft Tissue Pathology Fellowship at The University of Texas MD Anderson Cancer Center in Houston, TX (2019-2020).

IMPACT AND INFLUENCE:

My role as the AP/CP Pathology Chief Resident at Virginia Commonwealth University Health System (2017-2018) allowed me to contribute significantly to the department's operations. I played a pivotal role in bridging clinical and anatomical aspects, fostering a comprehensive understanding of pathology.

ACADEMIC CITES:

In 2018, I achieved board certification in Anatomic Pathology/Clinical Pathology (AP/CP) from the American Board of Pathology, affirming my proficiency and dedication to maintaining the highest standards in the field.

LEGACY AND FUTURE CONTRIBUTIONS:

Since 2020, I have served as an Assistant Professor of Clinical Pathology & Laboratory Medicine at Indiana University School of Medicine. In this capacity, I continue to impart knowledge, mentor future pathologists, and contribute to the advancement of pathology through my clinical work and research endeavors.

HIGHLIGHTS:

My commitment to excellence is underscored by my continuous pursuit of knowledge and certifications, including my current Indiana Medical License (expiring 10/31/2025) and my status as a Basic Life Support (BLS) Provider certified by the American Heart Association.

FUTURE CONTRIBUTIONS:

Looking ahead, I am dedicated to furthering research, education, and patient care in the realm of pathology. I aspire to make enduring contributions to the field, leaving a lasting legacy through my dedication to excellence, mentorship, and continued pursuit of knowledge.

Notable publications:

Atypical cartilage in type II germ cell tumors of the mediastinum show significantly different patterns of IDH1/2 mutations from conventional chondrosarcoma 2022(1)

“PRRX1-rearranged mesenchymal tumors”: expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature 2022(3)

NR1D1::MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature 2023(1)

Birgit Schilling | X-linked dystonia-parkinsonism (XDP) and Proteomics | Best Researcher Award

Posted on 10/01/202417/02/2024 by PencisLeave a Comment

Prof Dr. Birgit Schilling | X-linked dystonia-parkinsonism (XDP) and Proteomics | Best Researcher Award

Buck Institute for Research on Aging | United States

Author Profile

Scopus

EARLY ACADEMIC PURSUITS:

With a career spanning over two decades, you began your academic journey with a focus on protein chemistry and mass spectrometric technologies. These early academic pursuits laid the foundation for your expertise in proteomics, specifically within the context of aging research.

PROFESSIONAL ENDEAVORS:

Your professional endeavors have been diverse and impactful. As the Director of the Mass Spectrometry Center at the Buck Institute for Research on Aging, you have played a pivotal role in advancing research projects across various domains, from neurodegenerative diseases to cancer, diabetes, mitochondrial damage, and bacterial pathogenesis. Your involvement in national U01 consortiums and U54 Tissue Mapping Center reflects your commitment to collaborative, cutting-edge research.

CONTRIBUTIONS AND RESEARCH FOCUS ON X-LINKED DYSTONIA-PARKINSONISM (XDP) AND PROTEOMICS:

Your contributions to the field of proteomics are noteworthy, particularly in the molecular mechanisms of aging and protein posttranslational modifications. Your engagement in a P01 program project grant and the Senescence Network SenNet initiative underscores your dedication to understanding senescence and its implications. The investigation of the senescence-associated secretory phenotype (SASP) in neurodegeneration highlights your pursuit of unraveling critical aspects of aging-related processes.

IMPACT AND INFLUENCE:

Collaborations with esteemed researchers, including Drs. Ellerby and Campisi, showcase the impact and influence you've had in your field. Your multi-PI roles, leadership in a 'Senescence Core,' and participation in a P30 Nathan Shock Center award underscore your leadership and influence in shaping research agendas and collaborative efforts.

ACADEMIC CITES:

Your extensive collaborations and publications, spanning over 20 years with Drs. Ellerby and Campisi, contribute significantly to the academic literature. The depth and breadth of your work have likely resulted in numerous citations, reflecting the scholarly impact of your research within the scientific community.

LEGACY:

As a leader in proteomics and aging research, your legacy is marked by a prolific body of work and collaborative initiatives. Your role in technology development awards and organ-on-a-chip systems further cements your legacy as a forward-thinking scientist driving innovation in the field.

FUTURE CONTRIBUTIONS:

Looking ahead, your involvement in ongoing studies for Huntington's and Alzheimer's disease, as well as your exploration of the SASP in neurodegeneration, positions you for continued influential contributions. Your leadership in various consortia and core facilities suggests a future marked by continued advancements at the intersection of mass spectrometry, proteomics, and aging research.

Notable Publications:

Coenzyme A binding sites induce proximal acylation across protein families 2023 (1)

Senescent cells perturb intestinal stem cell differentiation through Ptk7 induced noncanonical Wnt and YAP signaling 2023(4)

Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD 2023(3)

Xukun Deng | Pharmacogenomics and Personalized Medicine | Excellence Award

Posted on 09/01/202419/02/2024 by PencisLeave a Comment

Prof. Xukun Deng | Pharmacogenomics and Personalized Medicine | Excellence Award

South-Central Minzu University | China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS:

Dr. XU-KUN DENG commenced his academic journey by obtaining a Bachelor of Science degree in PHARMACY from the Department of Pharmacy at ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE between 1990 and 1994.

PROFESSIONAL ENDEAVORS:

In his pursuit of academic excellence, Dr. DENG furthered his studies at the School of Pharmacy, NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, from 2000 to 2006. During this period, he demonstrated exceptional dedication and prowess, earning a Ph.D. degree in TRADITIONAL CHINESE MEDICINE. His academic achievements were recognized with the prestigious QIUSHI SCHOLARSHIP in HONG KONG in 2006.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENOMICS AND PERSONALIZED MEDICINE:

Since 2007, Dr. DENG has held the position of a PROFESSOR and POSTGRADUATE TUTOR at the School of Pharmacy, SOUTH-CENTRAL MINZU UNIVERSITY. His extensive contributions to the field encompass a broad spectrum, including PHARMACOLOGY, NATURAL MEDICINE CHEMISTRY, and CHINESE MEDICINE PROCESSING.

IMPACT AND INFLUENCE:

Dr. DENG's work holds significant impact, particularly in the realms of GASTROINTESTINAL PHARMACOLOGY and TUMOR PHARMACOLOGY. His dedication to uncovering NEW ACTIVE CONSTITUENTS of TRADITIONAL CHINESE MEDICINE underscores his commitment to advancing scientific knowledge and medical practices.

ACADEMIC CITATIONS:

His research contributions have garnered recognition, evident in the academic world through numerous citations and acknowledgments. Dr. DENG's work has left a lasting imprint on the academic landscape, influencing fellow researchers and contributing to the collective knowledge in his areas of expertise.

LEGACY AND FUTURE CONTRIBUTIONS:

As a respected figure in his field, Dr. XU-KUN DENG's legacy is marked by a commitment to excellence and a profound impact on the understanding of Traditional Chinese Medicine. His continued dedication to research and education positions him as a beacon for future scholars and practitioners in the field. The legacy he is building promises to shape the trajectory of research in pharmacology, natural medicine chemistry, and Chinese medicine processing for years to come.

Notable Publications

Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl₄-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade 2022 (15)

A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl₄-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade 2021(8)

Luigi Maione | Endocrinology | Best Research Award

Posted on 06/01/202419/02/2024 by PencisLeave a Comment

Dr. Luigi Maione | Endocrinology | Best Research Award

Paris Saclay University | France

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Degrees (a to h)

Postdoctoral Fellowship at Harvard Medical School (2019-2020)
Diplôme Inter Universitaire (DIU) in Genetic Diseases (2018)
DIU in Ultrasound and Ultrasonic Techniques (2018)
DU in Hypothalamo-Hypophysial Pathology (2010)
PhD in Oncology and Molecular Endocrinology (2015)
Master's Degree in Paris-XI Sud University (2012)
Specialization Degree in Endocrinology (2011)
Degree in Medicine and Surgery (2005)

PROFESSIONAL ENDEAVORS

Clinical Activities (a to d)

Maitre de Conférences – Praticien Hospitalier (MCU-PH) at Paris-Saclay University (since Sep 2023)
PHU at Paris-Saclay University (Nov 2020 - Aug 2023)
Director of CRMR HYPO (since Nov 2023)
Coordinator of Thyroid Disease Clinical Activity (since Nov 2015)

CONTRIBUTIONS AND RESEARCH FOCUS ON ENDOCRINOLOGY

Research Activities

Research Unit (UMRS 1185) – Endocrine Physiology and Pathophysiology (since 2021)
Research Domain: Neuroendocrinology of the Gonadotrope Axis
Clinical Research Projects: Hypogonadism, Acromegaly, Thyroidology

IMPACT AND INFLUENCE

Teaching Activities

Coordinator of DU in Reproductive Endocrinology (since 2019/2020)
Coordinator of Reproductive Endocrinology Module at Master 2 (Paris-Saclay University)
Various Teaching Modules within the Faculty of Medicine and Radiologic Technologist Programs
Contributor to Post-Residency Courses in Endocrinology and related fields

SIAPS Score for Pedagogic Activities: 272.5 (Updated in February 2022)

ACADEMIC CITATIONS

Patents and Awards

National Italian Patent for Sensorineural Test (Flavor Test)
Fonds d’Intervention Régional (FIR) for CYTO-TRAIN Project (2022)

LEGACY AND FUTURE CONTRIBUTIONS

Given the extensive academic background, clinical expertise, and involvement in research and teaching, the legacy is marked by a significant impact on rare pituitary diseases, thyroid disorders, and reproductive endocrinology. Future contributions are anticipated in furthering research, mentoring students, and advancing clinical care in endocrinology.

Notable Publications

IGF-I variability over repeated measures in patients with acromegaly under long-acting somatostatin receptor ligands 2022(3)

Reproductive Phenotypes in Men With Acquired or Congenital Hypogonadotropic Hypogonadism: A Comparative Study 2022(5)

Muhammed Dawood | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Posted on 05/01/202419/02/2024 by PencisLeave a Comment

Mr. Muhammed Dawood | Pharmacogenomics and personalized medicine | Best Researcher Award

Computer Science Department | United Kingdom

Author Profile

Google Scholar

EARLY ACADEMIC PURSUITS

Muhammad Dawood's academic journey began with a Bachelor's in Computer Software Engineering from the University of Engineering and Technology (UET) Peshawar, Pakistan, where his thesis explored a novel approach for Quran learning using Neuro-Linguistic Programming (NLP) and Total Physical Interaction (TPI) in handheld devices. He continued his studies with a Master's in Computer Science from the Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, focusing on the analysis of hurricane satellite imagery.

PROFESSIONAL ENDEAVORS

Following his master's, Dawood gained teaching and industrial experience. As a Lecturer at the Department of Software Engineering, University of Science & Technology Bannu, Pakistan, he taught various courses, supervised undergraduate final year projects, and served as a coordinator. Additionally, he worked as a Machine Learning Engineer at INTAQSOL Islamabad, Pakistan, before embarking on his Ph.D. journey at the TIA Research Centre, Computer Science Department, University of Warwick.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENOMICS AND PERSONALIZED MEDICINE

Dawood's contributions span a diverse range of projects, reflecting his expertise in computational pathology, genomic data science, machine learning, and software engineering. Notable projects include gene expression prediction, cellular composition prediction, and drug sensitivity prediction from histology images. His research also delves into hurricane intensity prediction, personalized aesthetic-based apparel recommendation, and sentiment analysis of Twitter tweets.

IMPACT AND INFLUENCE

Muhammad Dawood's impactful work is underscored by numerous achievements. He secured a fully funded studentship for his Ph.D. studies from GlaxoSmithKline and received the Best Paper Award at ICCV CDpath 2021. His teaching contributions as a Graduate Teaching Assistant at the University of Warwick further showcase his commitment to academic excellence.

ACADEMIC CITES

Dawood's research, particularly in the field of computational pathology and genomics, has likely garnered attention within the academic community. While specific citation metrics are not provided, his Best Paper Award at ICCV CDpath 2021 suggests recognition and appreciation for the quality of his work.

LEGACY AND FUTURE CONTRIBUTIONS

As a fourth-year Ph.D. student, Dawood's legacy includes a diverse portfolio of projects that contribute to the understanding of cellular processes, cancer therapy personalization, and drug design. His future contributions are anticipated to further advance the fields of machine learning, computational pathology, and genomic data science, leaving a lasting impact on personalized medicine and beyond.

Notable Publications

SlideGraph+: Whole slide image level graphs to predict HER2 status in breast cancer 2022(47)

Deep-PHURIE: deep learning based hurricane intensity estimation from infrared satellite imager 2020(37)

CoNIC Challenge: Pushing the frontiers of nuclear detection, segmentation, classification and counting 2023(5)

Alban Deo Christian | Chirurgie Maxillo-Faciale | Young Scientist Award

Posted on 03/01/202419/02/2024 by PencisLeave a Comment

Dr. Alban Deo Christian | Chirurgie Maxillo-Faciale | Young Scientist Award

CHU Mohammed VI, Marrakech | Morocco

AUTHOR PROFILE

ORCID Id

EARLY ACADEMIC PURSUITS

Alban Déo Christian OPANGO began his academic journey in Brazzaville, Congo, achieving academic excellence early on. In 2002, he obtained the Certificate of Primary and Elementary Studies (CEPE), followed by the Brevet d’Etudes du Premier Cycle (BEPC) in 2006. His commitment to education continued as he earned the BACCALAUREAT SERIE C Diploma in June 2009, specializing in mathematics with a focus on physical sciences.

PROFESSIONAL ENDEAVORS

Embarking on a career in medicine, OPANGO commenced medical studies at the Faculty of Health Sciences, Marien Ngouabi University, in October 2009. This academic pursuit spanned from October 2009 to June 2017, shaping the foundation of his medical knowledge and skills.

CONTRIBUTIONS AND RESEARCH FOCUS ON CHIRURGIE MAXILLO-FACIALE

OPANGO's research culminated in a significant thesis titled "Anatomo-scanographic Study of the Arterial Vascularization of the Liver in Congolese Melanoderma Subjects." Defended on December 4, 2017, at the Faculty of Health Sciences, Marien Ngouabi University, the thesis garnered high praise, earning him a "Very Honorable" mention with congratulations from the jury.

IMPACT AND INFLUENCE

Following his academic achievements, OPANGO delved into professional experiences that showcased his dedication to healthcare. From September 2016 to December 2018, he served as a Doctor at the Talangai Reference Hospital, contributing to the well-being of the community. Additionally, his role as a Contract Doctor at the Maison Médicale France – Congo Clinic (MMFC) from January 2017 to December 2018 further expanded his professional repertoire.

ACADEMIC CITES

OPANGO's contributions extend beyond clinical practice, with a focus on academic excellence. In April 2023, he obtained a Certificate in the Management of Health Establishments, demonstrating his commitment to continuous learning and professional development.

LEGACY AND FUTURE CONTRIBUTIONS

With a robust educational background, successful thesis defense, and impactful professional experiences, OPANGO has laid the groundwork for a promising career in the medical field. His legacy includes a commitment to excellence, research, and the provision of quality healthcare services. As he navigates the path ahead, OPANGO is poised to make further contributions to the medical community and society at large.

Notable Publications

Eccrine spiradenoma of nose: Surgical case report 2023